Les Hopitaux Universitaires De Strasbourg

At Les Hopitaux Universitaires De Strasbourg, the Service Pneumologie is strongly involved in studies on respiratory tract diseases and neoplasms, with a major focus on non-small cell lung cancer, small cell lung cancer, and pleural mesothelioma. These trials are exploring new treatment approaches and combinations to improve survival, control disease progression, and expand options for patients with advanced lung cancers.

• Evaluating new cancer therapies for advanced and metastatic lung cancer
• Assessing treatment combinations to improve overall survival and disease control
• Studying targeted approaches for specific tumor subtypes and genetic profiles

This research reflects a broad effort to refine care for complex thoracic cancers, especially where current treatment choices remain limited.

The site is also active in studies of respiratory infections and bacterial diseases, including hospital-acquired bacterial pneumonia, ventilator-associated pneumonia, and severe community-acquired pneumonia. In addition, trials address uncommon infections such as Mycobacterium xenopi pulmonary infection, with the goal of improving infection control, treatment effectiveness, and recovery in hospitalized and critically ill patients.

• Testing better strategies for pneumonia treatment in intensive care and hospital settings
• Evaluating therapies for difficult-to-treat pulmonary infections
• Supporting faster clinical recovery and better infection outcomes

This area highlights an important balance between managing common severe infections and addressing less frequent but challenging respiratory pathogens.

Clinical research at this center includes several immune system diseases and autoimmune disorders, such as systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, and idiopathic inflammatory myopathies. These studies aim to improve symptom control, reduce inflammation, and identify more effective long-term treatment strategies for patients with chronic immune-related illness.

• Testing therapies for lupus, rheumatoid arthritis, and related inflammatory diseases
• Exploring options to improve muscle and organ function in myopathies
• Evaluating treatments that may better control persistent autoimmune activity

The Service Pneumologie contributes to a wider immunology-focused research portfolio that connects respiratory symptoms with systemic inflammatory disease.

The site conducts trials in cardiovascular diseases, hemic and lymphatic diseases, and pathological conditions related to clotting and bleeding. Research topics include atrial fibrillation, acute myocardial infarction, venous thromboembolism, deep vein thrombosis, and hemophilia A, with studies aimed at preventing complications and improving treatment safety.

• Studying ways to reduce stroke and systemic embolism risk
• Evaluating therapies for blood clots and clot breakdown
• Improving prevention and long-term management of bleeding disorders

This research supports better balance between clot prevention and bleeding risk across a range of cardiovascular and hematologic conditions.

Another important research area covers digestive system diseases and nutritional and metabolic diseases, including hepatocellular carcinoma, nonalcoholic steatohepatitis, metabolic dysfunction-associated steatohepatitis, and hepatic encephalopathy. Trials in this field are focused on improving liver-related outcomes, easing symptoms, and slowing disease progression in patients with chronic liver conditions.

• Testing new approaches for liver disease and liver-related complications
• Evaluating treatments for fatty liver disease and fibrosis
• Seeking better control of symptoms such as pruritus and encephalopathy

These studies address both advanced liver disease and earlier stages of metabolic liver injury, reflecting a broad clinical interest in hepatology.

The research portfolio also includes nervous system diseases and psychiatry and psychology, with studies in multiple sclerosis, tuberous sclerosis complex-related epilepsy, idiopathic hypersomnia, and behavioral addictions. These trials are designed to improve symptom management, reduce disease activity, and better understand conditions that affect daily functioning and quality of life.

• Assessing therapies for relapsing multiple sclerosis and other neurological disorders
• Studying treatment options for epilepsy linked to tuberous sclerosis complex
• Exploring approaches for sleep disorders and addictive behaviors

This combination of neurologic and behavioral research shows a strong interest in conditions that can be chronic, disruptive, and difficult to treat.

Les Hopitaux Universitaires De Strasbourg is also involved in studies on kidney transplantation, food allergy, and several rare or specialized conditions such as Goodpasture disease, pulmonary arterial hypertension, and arrhythmogenic right ventricular dysplasia. These trials often aim to improve prevention, safety, and long-term outcomes in patients with complex or uncommon diseases.

• Improving care after kidney transplantation
• Testing ways to reduce allergic reactions and support desensitization
• Evaluating new options for rare diseases and hard-to-manage chronic conditions

The site’s activity in these areas adds depth to its broader clinical research profile and supports care for patients with less common needs.